Direxion Daily CSI China Internet Bull 2X Shares vs Erasca Inc. Common Stock — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.94 (market cap $173.62M), while Erasca Inc. Common Stock trades at $15.89 (market cap $5.40B). The key difference: Erasca Inc. Common Stock is far larger — about 31.1× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Erasca Inc. Common Stock for 0 Days on average.
| CWEB | ERAS | |
|---|---|---|
Market Cap | $173.62M | $5.40B |
Volume | 551,726 | 9,533,185 |
Sector | Leveraged / Inverse | Health |
52-Week High | $55.62 | $22.47 |
52-Week Low | $17.39 | $2.20 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | — | $5.18B |
Signals from Pluang's Aura AI — not financial advice
CWEB is trading at $18.02, down 1.85% on the day, with technical indicators showing a bearish trend across moving averages. The stock faces selling pressure with all 13 moving average signals bearish and key resistance levels clustered around $18. Recent news highlights China's AI ambitions and potential growth in China tech stocks as catalysts.
The outlook remains cautious due to technical weakness, though exposure to China's growing AI sector offers long-term potential. Key risks include China market volatility and competitive pressures. Investors should monitor earnings reports for fundamental validation of growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →